SEC 13F Intelligence

Tybourne Capital Management (Hk) Ltd / AMLX

Tybourne Capital Management (Hk) Ltd’s Amylyx Pharmaceuticals Inc Position

Does Tybourne Capital Management (Hk) Ltd own Amylyx Pharmaceuticals Inc (AMLX)? Not currently — the last reported position was 768.6K shares worth $15M in Q2 2022; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$15M
Q2 2022
Shares
768.6K
% of Portfolio
+1.07%
Quarters Held
2
position exited

Position History AMLX

Reported value by quarter
Q1 ’22: $10MQ1 ’22Q2 ’22: $15MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2022768.6K$15M+1.07%
Q1 2022768.6K$10M+0.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tybourne Capital Management (Hk) Ltd’s full portfolio or all institutional holders of AMLX.